On November 18, 2024, Humacyte, Inc. was sued for violations of the federal securities laws in the United States District Court for the Middle District of North Carolina on behalf of investors who purchased or otherwise acquired Humacyte securities between May 10, 2024 and October 17, 2024, inclusive (the “Class Period”).
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.